Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 861177 NEW YORK, NY

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,593,196
-$132,792 QoQ
Shares Held
44,011
-15.7% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 45% Shared 0% None 55%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. COLL ranks #21 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,593,196 44,011
2026-03-31 $1,725,988 52,192
2025-12-31 $2,476,678 53,492
2025-09-30 $1,994,987 57,016
2025-06-30 $2,802,850 94,787
2025-03-31 $2,119,767 71,014
2024-12-31 $1,902,044 66,389
2024-09-30 $2,292,354 59,326
2024-06-30 $2,231,780 69,310
2024-03-31 $1,192,898 30,729
2023-12-31 $945,836 30,729
2023-09-30 $686,791 30,729
2023-06-30 $660,364 30,729
2023-03-31 $737,186 30,729
2022-12-31 $850,418 36,656
2022-09-30 $476,064 29,717
2022-06-30 $498,976 28,159
2022-03-31 $584,636 28,715
2021-12-31 $536,395 28,715
2021-09-30 $566,833 28,715
2021-06-30 $678,821 28,715
2021-03-31 $673,648 28,424
2020-12-31 $609,591 30,434
2020-09-30 $574,881 27,612
2020-06-30 $491,260 28,072
2020-03-31 $4,126,426 252,690